A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates

P. Miller; N. Pannacciulli; J.P. Brown; E. Czerwinski; S. Nedergaard; M.A. Bolognese; J. Malouf; H.G. Bone; Jean-Yves Reginster; A. Singer; A. Wang; R.B. Wagman; S.R. Cummings

A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates

Conference proceeding

Peer reviewed

A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates

P. Miller, N. Pannacciulli, J.P. Brown, E. Czerwinski, S. Nedergaard, M.A. Bolognese, J. Malouf, H.G. Bone, Jean-Yves Reginster, A. Singer, …

Osteoporosis International, 27 (SUPPLEMENT1), 42 (2016-04); World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Malaga, Spain [ES], du 14 au 17 avril 2016

04/2016

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates
Creators - without role: P. Miller
N. Pannacciulli
J.P. Brown
E. Czerwinski
S. Nedergaard
M.A. Bolognese
J. Malouf
H.G. Bone
Jean-Yves Reginster
A. Singer
A. Wang
R.B. Wagman
S.R. Cummings
Conference: Osteoporosis International, 27 (SUPPLEMENT1), 42 (2016-04); World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Malaga, Spain [ES], du 14 au 17 avril 2016
Publisher: Springer Science & Business Media B.V
Identifiers: 9952894908331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding